Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors.

Jackson EM, Sievert AJ, Gai X, Hakonarson H, Judkins AR, Tooke L, Perin JC, Xie H, Shaikh TH, Biegel JA.

Clin Cancer Res. 2009 Mar 15;15(6):1923-30. doi: 10.1158/1078-0432.CCR-08-2091.

2.

A complex karyotype in an atypical teratoid/rhabdoid tumor: case report and review of the literature.

Coccé MC, Lubieniecki F, Kordes U, Alderete D, Gallego MS.

J Neurooncol. 2011 Aug;104(1):375-80. doi: 10.1007/s11060-010-0478-0. Review.

PMID:
21127945
3.

Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.

Kim KH, Roberts CW.

Cancer Genet. 2014 Sep;207(9):365-72. doi: 10.1016/j.cancergen.2014.04.004. Review.

4.

INI1-deficient tumors: diagnostic features and molecular genetics.

Hollmann TJ, Hornick JL.

Am J Surg Pathol. 2011 Oct;35(10):e47-63. doi: 10.1097/PAS.0b013e31822b325b. Review.

PMID:
21934399
5.

The role of SMARCB1/INI1 in development of rhabdoid tumor.

Roberts CW, Biegel JA.

Cancer Biol Ther. 2009 Mar;8(5):412-6. Review. No abstract available.

6.

Molecular genetics of atypical teratoid/rhabdoid tumor.

Biegel JA.

Neurosurg Focus. 2006 Jan 15;20(1):E11. Review.

PMID:
16459991
7.

Pathology and diagnosis of SMARCB1-deficient tumors.

Margol AS, Judkins AR.

Cancer Genet. 2014 Sep;207(9):358-64. doi: 10.1016/j.cancergen.2014.07.004. Review.

PMID:
25246033
8.

The expanding family of SMARCB1(INI1)-deficient neoplasia: implications of phenotypic, biological, and molecular heterogeneity.

Agaimy A.

Adv Anat Pathol. 2014 Nov;21(6):394-410. doi: 10.1097/PAP.0000000000000038. Review.

PMID:
25299309
9.

Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy.

Kerl K, Holsten T, Frühwald MC.

Pediatr Hematol Oncol. 2013 Oct;30(7):587-604. doi: 10.3109/08880018.2013.791737. Review. Erratum in: Pediatr Hematol Oncol. 2014 Sep;31(6):581.

PMID:
23848359
10.

Molecularly confirmed primary malignant rhabdoid tumor of the urinary bladder: implications of accurate diagnosis.

Savage N, Linn D, McDonough C, Donohoe JM, Franco A, Reuter V, Biddinger PW, Eaton KW, Biegel JA, Sharma S.

Ann Diagn Pathol. 2012 Dec;16(6):504-7. doi: 10.1016/j.anndiagpath.2011.04.008. Review.

11.

Adult Atypical Teratoid/Rhabdoid Tumors.

Wu WW, Bi WL, Kang YJ, Ramkissoon SH, Prasad S, Shih HA, Reardon DA, Dunn IF.

World Neurosurg. 2016 Jan;85:197-204. doi: 10.1016/j.wneu.2015.08.076. Review.

PMID:
26344637
12.

SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: clinicopathologic and molecular study of a highly aggressive variant with literature review.

Agaimy A, Rau TT, Hartmann A, Stoehr R.

Am J Surg Pathol. 2014 Jul;38(7):910-20. doi: 10.1097/PAS.0000000000000173. Review.

PMID:
24503755
13.

Biology and Treatment of Rhabdoid Tumor.

Geller JI, Roth JJ, Biegel JA.

Crit Rev Oncog. 2015;20(3-4):199-216. Review.

PMID:
26349416
14.
15.

Atypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease.

Bikowska B, Grajkowska W, Jóźwiak J.

Eur J Neurol. 2011 Jun;18(6):813-8. doi: 10.1111/j.1468-1331.2010.03277.x. Review.

PMID:
21159066
16.

SWI/SNF chromatin remodeling complexes and cancer.

Biegel JA, Busse TM, Weissman BE.

Am J Med Genet C Semin Med Genet. 2014 Sep;166C(3):350-66. doi: 10.1002/ajmg.c.31410. Review.

17.

Rhabdoid tumors: an initial clue to the role of chromatin remodeling in cancer.

Lee RS, Roberts CW.

Brain Pathol. 2013 Mar;23(2):200-5. doi: 10.1111/bpa.12021. Review.

PMID:
23432645
18.

Malignant rhabdoid tumors: a familial condition?

Anderson J.

Pediatr Blood Cancer. 2011 Jan;56(1):1-2. doi: 10.1002/pbc.22834. Review. No abstract available.

PMID:
21108435
19.

Chromatin remodeling: from transcription to cancer.

Yaniv M.

Cancer Genet. 2014 Sep;207(9):352-7. doi: 10.1016/j.cancergen.2014.03.006. Review.

PMID:
24825771
20.

Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy.

Trobaugh-Lotrario AD, Finegold MJ, Feusner JH.

Pediatr Blood Cancer. 2011 Sep;57(3):423-8. doi: 10.1002/pbc.22857. Review.

PMID:
21744471

Supplemental Content

Support Center